NCT00220298View on ClinicalTrials.gov

Assessment of Long Term Treatment With Testosterone Undecanoate in Males With Hypogonadism

PHASE3CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Hypogonadism
Interventions
DRUG

Testosterone undecanoate (TU) - NebidoTM

Drug treatment with 14 injections of one ampoule of Nebido (1000 mg of testosterone undecanoate) at individually adjusted injection intervals

Trial Locations (14)

10249

Berlin

12159

Berlin

35037

Marburg

38440

Wolfsburg

48129

Münster

90441

Nuremberg

04299

Leipzig

06112

Halle

06618

Naumburg

07607

Eisenberg

07551

Gera

07740

Jena

07743

Jena

04289

Leipzig

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY